Here's Why Esperion Therapeutics Is Rocketing Higher
April 01, 2015 at 09:25 AM EDT
UBS released a statement on Esperion Therapeutics Inc (NASDAQ: ESPR) after its analysis of the opportunity and likely utilization of ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|